Results
Differentially Expressed miRNAs List
miRNA ID | Source ID | Cancer Type | Cancer Subtype | Cell Line | Design | logFC | Expression Status | Experiment ID |
---|---|---|---|---|---|---|---|---|
hsa-miR-217 | GSE5244 | uterus cancer | uterus cancer | N/A | cancer vs normal | -0.30 | DOWN | EXP00030 |
hsa-miR-217 | GSE6636 | prostate cancer | prostate cancer | N/A | cancer vs normal | 2.20 | UP | EXP00032 |
hsa-miR-217 | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | 0.24 | UP | EXP00090 |
hsa-miR-217 | GSE22058 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 0.17 | UP | EXP00100 |
hsa-miR-217 | GSE16558 | lymphoma | lymphoma | N/A | cancer vs normal | -0.45 | DOWN | EXP00076 |
hsa-miR-217 | GSE6857 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 0.49 | UP | EXP00081 |
hsa-miR-217 | GSE13030 | brain cancer | brain cancer | N/A | cancer vs normal | -1.31 | DOWN | EXP00066 |
hsa-miR-217 | GSE15008 | lung cancer | lung cancer | N/A | cancer vs normal | 0.75 | UP | EXP00070 |
hsa-miR-217 | GSE2564 | leukemia | leukemia | N/A | subtype1 vs substype2 | -0.26 | DOWN | EXP00026 |
hsa-miR-217 | GSE4589 | breast cancer | breast cancer | N/A | cancer vs normal | 2.22 | UP | EXP00029 |
hsa-miR-217 | GSE13030 | brain cancer | brain cancer | N/A | cancer vs normal | -1.06 | DOWN | EXP00065 |
hsa-miR-217 | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | 0.24 | UP | EXP00091 |
hsa-miR-217 | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | 0.33 | UP | EXP00092 |
hsa-miR-217 | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | 0.30 | UP | EXP00093 |
hsa-miR-217 | GSE21362 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 1.01 | UP | EXP00117 |